Skip to main content

Table 1 Demographic and clinical characteristics

From: Metastasis to lateral lymph nodes with no mesenteric lymph node involvement in low rectal cancer: a retrospective case series

  Entire sample (n = 42) meso+, lat+ (n = 26) meso+, lat− (n = 4) meso−, lat+ (n = 5) meso−, lat− (n = 7)
Age (years), mean ± SD 58.79 ± 10.69 58.23 ± 11.14 64.75 ± 12.09 58.80 ± 6.53 57.43 ± 11.66
Male sex, n (%) 24 (57.1) 16 (61.5) 2 (50.0) 2 (40.0) 4 (57.1)
BMI (kg/m2), mean ± SD 24.61 ± 3.37 24.48 ± 3.37 24.52 ± 5.32 25.56 ± 3.56 24.64 ± 2.72
Distance from AV (cm), median (range) 4.8 (0–8) 4.55 (0–8) 5.65 (1–8) 4.8 (3–5.5) 5.6 (3.5–8)
cT Stage, n (%)
 ct2 2 (4.8)     1 (14.3)
 cT3 31 (73.8) 21 (80.8) 3 (75.0) 4 (80.0) 4 (57.1)
 cT4 9 (21.4) 5 (19.2) 1 (25.0) 1 (20.0) 2 (28.6)
cN Stage, n (%)
 cN1 21 (50.0) 10 (38.5) 1 (25) 5 (100) 4 (57.1)
 cN2 21 (50.0) 16 (61.5) 3 (75)   3 (42.9)
nCRT, n (%) 16 (38.1) 10 (38.5) 1 (25.0) 2 (40) 3 (42.9)
  1. AV anal verge, BMI body mass index, lat lateral lymph nodes, meso mesenteric lymph nodes